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LIST OF ABBREVIATION 
 
6-4 PP  Pyrimidine (6-4) pyrimidone photoproduct 
BER  Base excision repair 
DMEM Dulbecco's Modified Eagle medium 
CHO  Chinese hamster ovary  
CNT  Centrin 2  
CPD  Cyclobutane pyrimidine dimer 
CS  Cockayne syndrome 
DDB  DNA-binding protein 
DNA  Deoxyribonucleic acid  
DPX  DNA-protein crosslink 
DsRed Red fluorescent protein from Discosoma sp. 
ECFP  Enhanced cyan fluorescence protein 
EGFP  Enhanced green fluorescence protein  
ERCC1 Excision repair cross-complementing 1 
EYFP  Enhanced yellow fluorescence protein 
FA  Formaldehyde 
FBS  Fetal bovine serum 
FRAP  Fluorescence recovery after photobleaching 
GFP  Green fluorescence protein 
GGR  Global genome repair  
IARC  International Agency for Research on Cancer 
mRFP  Monomeric red fluorescence protein  
NER  Nucleotide excision repair  
PBS  Phosphate-buffered saline 
RAD23B RAD23 homolog B 
ROI  Region of interest  
RPA  Replication protein A 
TCR  Transcription-coupled repair  
TFIIH  Transcription factor IIH  
Ub  Ubiquitin 
UV  Ultraviolet 
wt  Wild-type  
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 1  SUMMARY 
 
The genetic information is constantly exposed to physical and chemical DNA-
damaging agents. To safeguard genome stability, nucleotide excision repair (NER) is 
a protective system that processes a wide diversity of structurally unrelated DNA 
lesions, including UV-induced photoproducts and cisplatin intrastrand crosslinks. The 
aim of this thesis was to establish novel fluorescent protein-based imaging 
techniques to study NER activity in living fibroblasts and to apply these methods to 
determine the mechanism by which low-dose formaldehyde, a widely used genotoxic 
chemical, inhibits DNA repair. The nuclear movements of NER factors were analyzed 
by measuring the kinetics of accumulation at lesion sites and by monitoring protein 
dynamics in fluorescence recovery after photobleaching (FRAP) experiments. In 
combination, this live-cell imaging approach reveals that formaldehyde, at non-
cytotoxic concentrations, impedes the intra-nuclear trafficking of the DNA damage 
recognition proteins DDB2 and XPC, thus retarding their recruitment to NER 
substrates. Further live-cell imaging experiments with fluorescently tagged ubiquitin 
suggest that DDB2 stimulates protein ubiquitylation in response to formaldehyde 
exposure. In conclusion, these findings indicate that formaldehyde-induced DNA-
protein crosslinks interfere with the normal trafficking of NER subunits, thus 
distracting these repair factors from their physiologic function in recognizing and 
processing mutagenic DNA lesions. 
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 2  INTRODUCTION 
 
 2.1  Live cell imaging 
 
For many years, the properties and activities of isolated proteins have been 
extensively studied under defined experimental conditions in vitro. However, such 
biochemical systems are not directly comparable to the situation in a living cell or 
organism, where proteins act in a complex macromolecular environment. Therefore, 
it is crucial to understand how proteins behave not only in isolation but also in this 
physiologic context in situ (Gierasch & Gershenson 2009). In particular, great efforts 
have been undertaken during the last years to visualize proteins in their intrinsic 
environment by fusing them to genetically encoded fluorescent tags (Chalfie et al. 
1994). 
Live cell imaging of fluorescently tagged molecules is a powerful new experimental 
approach that allows for the real-time monitoring of complex biological events. In 
combination with concurrent biochemical and structural studies on the proteins of 
interest, live cell imaging provides the opportunity to monitor the consequences of 
macromolecular interactions, posttranslational protein modifications and protein 
conformational changes that have been determined in vitro either with purified factors 
or various cell extracts. As a consequence, the imaging of fluorescently tagged 
proteins has become an essential tool to study protein kinetics and dynamics within 
the complex micro-environment of living cells (Day et al. 2006; Day & Schaufele 
2008). 
 
 
 2.1.1  Fluorescent proteins 
 
In 2008, Prof. Osamu Shimomura, Prof. Martin Chalfie and Prof. Roger Tsien were 
awarded the Nobel Prize in Chemistry for their work on fluorescent proteins. The 
green-fluorescent protein (GFP) in association with the blue light-emitting aequorin 
was first isolated from the jellyfish Aequora victoria by Prof. Shimomura. He found 
that the binding of calcium ions to aequorin leads to the release of blue light. The 
GFP partner absorbs the blue light and in turn emits a green-fluorescent signal 
(Shimomura et al. 1962; Shimomura et al. 1963; Morise et al. 1974).The 238 amino 
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acids of GFP assemble into a compact cylindrical structure, resembling a barrel, that 
is capped on both ends by short α-helical sections. This three-dimensional protein 
fold is crossed by another α-helix that includes the amino acid sequence Ser65-
Tyr66-Gly67, which builds the chromophore center involving an autocatalytic 
cyclization of the Tyr66 residue (Shimomura 1979; Ormö et al. 1996; Yang et al. 
1996). The chromophore is intrinsic to the primary structure of the GFP protein and 
the resulting fluorescence can only be detected when the chromophore is embedded 
within the complete GFP sequence (Li et al. 1997). After the initial cloning and 
complementary DNA sequencing, the group of Prof. Chalfie expressed GFP in E. coli 
and C. elegans, demonstrating that it can be used as a molecular tag to visualize 
specific proteins in living cells and whole organisms (Chalfie et al. 1994). Subsequent 
modifications of the original GFP amino acid sequence yielded a wide range of 
variants with different colors and improved photo-physical properties (Heim & Tsien 
1996). The enhanced GFP (EGFP) carries two amino acid substitutions shifting the 
major excitation peak from ~400 nm to ~490 nm wavelength. The argon-ion laser 
routinely used in confocal scanning laser microscopes emits at 488 nm yielding a 
much more efficient excitation of EGFP compared to the wild-type GFP (Cormack et 
al. 1996; Yang et al. 1996). Other widely used spectral variants included enhanced 
yellow-fluorescent protein (EYFP) and enhanced cyan-fluorescent protein (ECFP). 
EYFP contains four amino acid substitutions that shift the emission from green to 
yellowish-green. One of the amino acid substitutions in the ECFP sequence shifts the 
emission spectrum from green to cyan, while the other five mutations enhance the 
brightness and solubility of the protein (Heim & Tsien 1996). 
The color palette of fluorescent proteins was expanded by the discovery of a new 
red-shifted species, DsRed, from the coral Discosoma sp. (Matz et al. 1999). The 
chromophore of this red homolog of GFP has an extra double bond, which is 
responsible for the red shift (Gross et al. 2000). However, the slow and incomplete 
maturation and obligate tetramerization of DsRed greatly hindered its use as a fusion 
tag (Baird et al. 2000). Meanwhile, an improved monomeric variant of red fluorescent 
protein (mRFP) has been engineered (Campbell et al. 2002; Bevis & Glick 2002). 
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 2.1.2  Fluorescence recovery after photobleaching 
 
The fluorescence recovery after photobleaching (FRAP) technique has been 
developed to study the real-time dynamics of biomolecules in living cells (Edidin et al. 
1976). This method is, for example, a very useful tool to estimate the bound fraction 
of a protein compared to the freely diffusing counterparts in a given biological 
compartment. In the context of this thesis, FRAP is used to determine the DNA 
damage-induced changes in the mobility of DNA repair factors. In FRAP, the 
fluorescent tag of the fusion protein is irreversibly bleached within a defined area of 
interest of the cell or any other cellular compartment. Thereafter, the gradual recovery 
of fluorescence in the bleached area, taking place by protein diffusion, is monitored 
over a particular period of time. The final output of this real-time analysis is a display 
of the time course of fluorescence recovery, which reflects the proportion of mobile 
and immobile fractions of the protein (Figure 1). When all tagged molecules are freely 
mobile, there will be a complete recovery of fluorescence in the bleached region. If, 
on the other hand, all tagged molecules were immobile, no fluorescence recovery 
would be observed and the bleached area would remain dark. In the more frequent 
intermediate situation, fluorescence in the bleached area will partly recover, such that 
the percentage of recovery is a measure for the mobility of the tagged molecules. 
The respective immobile fraction represents a snapshot of a steady state binding 
equilibrium due to interactions with cellular structures (Cardarelli et al. 2009; van 
Royen et al. 2009; Kalla et al. 2006; Carrero et al. 2003).The example of Figure 1 
shows a typical FRAP experiment performed in human fibroblasts expressing a GFP-
tagged protein that is localized to the cell nucleus. The advanced technical 
requirements needed to perform this fluorescence-based live cell imaging technique 
includes a confocal microscope to clearly visualize a single optical plane in the three-
dimensional scaffold of living cells without any interference due to out-of-focus 
signals. 
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Figure 1: Example of a FRAP experiment in human fibroblasts expressing a GFP-
tagged nuclear protein. (A) Representative plot showing the protein dynamics 
resulting from its mobile and immobile fractions. (B) Schematic description of the 
FRAP procedure with the respective real-time images of a cell expressing the GFP 
tagged protein. Prebleach = before exposure to the argon laser (488 nm wavelength); 
bleach = irradiation of the ROI; postbleach = recovery of fluorescence after local 
bleaching. 
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 2.2  Maintenance of genomic stability 
 
Deoxyribonucleic acid (DNA) is the carrier of the genetic information. Although its 
long-term integrity is indispensable for the survival of cells, organisms and entire 
species, the DNA is continuously exposed to the damaging effects of several harmful 
endogenous and exogenous agents such as oxidative radicals, UV light, X-rays and 
electrophilic chemicals. These genotoxic insults cause a number of adverse 
consequences in the form of DNA damage: double strand breaks, single strand 
breaks, base modifications, base losses as well as photoproducts, DNA adducts, 
intrastrand or interstrand crosslinks and DNA-protein crosslinks (Greene 1992; 
Sancar 1996; Wood 1997; Barker et al. 2005; Friedberg et al. 2006; Lopes et al. 
2006). If left unrepaired, these DNA lesions may lead to cell death or, alternatively, to 
the accumulation of mutations eventually triggering the development of a tumor 
(Sancar 1996; Wood 1997). To avoid these detrimental consequences of DNA 
damage, mammalians developed various repair pathways. For example, double 
strand breaks are patched by homologous recombination or non-homologous end-
joining (Li & Heyer 2008; Yano et al. 2009) and oxidative base modifications are 
mainly processed by base excision repair (BER) (Baute & Depicker 2008). The 
present thesis is focused on the nucleotide excision repair (NER) pathway that is 
characterized by its capacity to recognize a broad range of lesions including UV 
photoproducts, DNA adducts and intrastrand DNA crosslinks. 
 
 
 2.2.1  Nucleotide excision repair 
 
As mentioned before, the NER pathway detects and processes a large diversity of 
structurally unrelated lesions, including bulky damages such as UV light-induced 
photoproducts, bulky oxidative lesions, carcinogen-DNA adducts and cisplatin-
induced intrastrand DNA crosslinks. All these NER substrates share the common 
property to distort the helical conformation of the DNA double helix (Satoh et al. 
1993; Reardon et al. 1997; Kuraoka et al. 2000; Dip et al. 2004; Reardon et al. 2006; 
Shivji et al. 2006). 
Defects in the NER pathway have been discovered in individuals suffering from the 
inherited syndromes Xeroderma pigmentosum (XP), Cockayne syndrome (CS) and 
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Trichothiodystrophy (de Boer & Hoeijmakers 2000). XP is a rare autosomal recessive 
disorder in humans. This genetic disease is mainly characterized by an extreme 
hypersensitivity to sunlight and a 2000-fold increased incidence of skin cancer, 
mainly squamous cell carcinomas, basal cell carcinomas and melanomas (Kraemer 
et al. 1984; Friedberg et al. 2006). XP patients also suffer from a higher risk of 
contracting internal tumors, in some cases combined with neurological complications 
(Satoh et al. 1993; D´Errico et al. 2006). Individuals affected by XP are classified in 7 
NER-deficient complementation groups designated XP-A through XP-G, which reflect 
mutations in distinct repair genes (Sancar 1996; Wood 1996; Andressoo et al. 2005). 
The respective NER proteins (XPA through XPG) were named after the 
corresponding genetic complementation group. 
 
 
 2.2.1.1  Global genome repair 
 
The NER system can be subdivided in two sub-pathways, “global-genome repair” 
(GGR) and “transcription-coupled repair” (TCR). The GGR sub-pathway removes 
DNA lesions from anywhere in the genome, whereas TCR only removes DNA 
damage from actively transcribed sequences (Hanawalt 2002; Maddukuri et al. 2007; 
Nouspikel 2009). Although many mechanistic details are still highly debated, a 
favored model proposes that these repair machineries are assembled on damaged 
DNA sites in a sequential manner. In particular, the GGR sub-pathway is initiated by 
the binding of XPC protein, together with RAD23B and the calcium-binding protein 
centrin 2 (CNT2), to target lesions as illustrated in Figure 2 (Volker et al. 2001; Nishi 
et al. 2005). The XPC subunit is able to detect damage-induced distortions of the 
DNA double helix by sensing abnormal strand oscillations (Sugasawa et al. 1998; 
Buterin et al. 2005; Maillard et al. 2007). The other components of the trimeric XPC 
complex, RAD23B and CNT2, stimulate GGR activity by stabilizing the XPC subunit 
via protection from proteasomal degradation and by promoting its DNA-binding 
function (Ng et al. 2003). After the recognition of damaged sites by the XPC complex, 
the GGR pathway proceeds by the recruitment of transcription factor TFIIH, a large 
factor consisting of 10 subunits that includes the two DNA helicases XPB and XPD. 
Using its DNA helicase subunits, TFIIH unwinds the damaged site by 20-25 
nucleotides generating an open intermediate (Mu et al. 1997). This local unwinding of 
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the duplex generates double-stranded to single-stranded DNA junctions at the edges 
of a central bubble, thus providing a preferred incision substrate for the two structure-
specific endonucleases XPF-ERCC1 and XPG (Drapkin & Reinberg 1994; 
O´Donovan et al. 1994; Bessho et al. 1997; Bienstock et al. 2003). The term ERCC1 
(for excision-repair-cross-complementing 1) denotes an interaction partner of XPF 
that is absolutely required for its stability and nuclease activity (Enzlin & Schärer 
2002). 
It has been reported that XPA and replication protein A (RPA) become incorporated 
into the nascent NER complex following the recruitment of TFIIH, whereas XPC-
RAD23B-CNT2 is displaced from the ultimate pre-incision intermediate (You et al. 
2003). The function of XPA protein is controversially discussed, but the proper 
association of XPA with the DNA intermediate is required for the assembly of a 
productive incision complex (Camenisch et al. 2006; Camenisch et al. 2007). 
Furthermore, XPA interacts with RPA, a single-stranded DNA-binding protein that 
protects the undamaged complementary strand from accidental endonucleolytic 
cleavage (de Laat et al. 1998). XPA and RPA, in combination, also provide a docking 
platform for XPG and XPF-ERCC1 (Matsunga et al. 1995; Mu et al. 1997). XPG 
performs the 3’ incision and the XPF-ERCC1 heterodimer is responsible for the 5’ 
incision. This dual incision reaction leads to the release of an oligonucleotide 
segment containing the offending DNA damage. The resulting single-stranded gap is 
filled by a DNA polymerase (δ, ε or κ) using the undamaged complementary strand 
as a template (Shivji et al. 1995; Araújo et al. 2000). Finally, the remaining nick 
between the newly synthesized DNA repair patch and the pre-existing strand is 
sealed by the action of DNA ligases. 
 
Figure 2: Scheme of the GGR pathway with the star symbolizing an offending DNA 
lesion. The following core NER factors are responsible for the GGR response in 
human cells: XPC-RAD23B-CNT2, TFIIH (containing the DNA helicases XPB and 
XPD), XPF-ERCC1, XPG, XPA, RPA, a DNA polymerase (POLδ, POLε or POLκ) and 
DNA ligases (see text for references). An accessory factor referred to as DDB (for 
damaged DNA-binding) stimulates the recognition and repair of UV lesions (Keeney 
et al. 1994; Hwang et al. 1999; Tang et al. 2000; Fitch et al. 2003; Moser et al. 2005) 
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 2.2.1.2  Transcription-coupled repair 
 
Unrepaired DNA lesions not only lead to the accumulation of genetic mutations but 
also interfere with the ongoing transcriptional process. The resulting inhibition of gene 
functions triggers cell cycle arrest, cell senescence (a permanent cell cycle block) or 
cell death by apoptosis (Mitchell et al. 2003). To prevent these adverse effects of 
DNA damage, living organisms have developed a transcription-coupled repair (TCR) 
sub-pathway that removes DNA lesions selectively from the transcribed strand of 
active genes. TCR is initiated when the RNA polymerase II complex stalls in the 
proximity of the lesions, followed by the sequential recruitment of TFIIH, XPA, RPA as 
well as XPG and XPF-ERCC1. XPC-RAD23B-CNT2, the key recognition factor in 
GGR, is dispensable for the TCR pathway (Venema et al. 1991; van Hoffen et al. 
1995). Instead, the TCR reaction depends on the two Cockayne syndrome (CS) 
genes, CSA and CSB. Several models of the TCR pathway propose that CSB protein 
interacts with the lesion-stalled RNA polymerase (Sarasin & Stary 2007) and then 
recruits other repair factors to the damaged site, including CSA which is part of an 
E3-ubiquitin ligase complex consisting of the three proteins DDB1, Cullin 4A and 
ROC1/Rbx1 (Groisman et al. 2003, Fousteri et al. 2006). 
 
 
 2.3  DNA lesions 
 
The presence of multiple repair pathways reflects the susceptibility of DNA to damage 
by various genotoxic insults (Camenisch & Naegeli 2009; Nouspikel 2009). In fact, 
DNA is not an intrinsically stable molecule and is subjected to constant attacks by a 
variety of endogenous and exogenous DNA-damaging agents. As outlined before, 
the NER pathway recognizes and repairs a remarkably broad range of lesions 
including UV photoproducts, certain oxidative lesions, carcinogen-DNA adducts and 
intrastrand DNA crosslinks. The same NER pathway has also been implicated in the 
removal of DNA-protein crosslinks (DPXs) (Reardon & Sancar 2006; Ide et al. 2008). 
Next, I will review shortly the NER substrates that are relevant for the present thesis. 
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 2.3.1  UV light-induced DNA photoproducts 
 
UV light is defined as electromagnetic radiation, with wavelength between 100 and 
400 nm, which is commonly subdivided into three ranges. UV-B is confined to 280 – 
315 nm, followed by UV-A with 315 – 400 nm. Both spectra penetrate at least in part 
through the atmospheric ozone layer and can be absorbed by the human skin 
(Mouret et al. 2006). Instead, the high-energy UVC range (100 to 280 nm) is entirely 
blocked by the ozone in the atmosphere and, therefore, does not reach the earth’s 
surface. Dependending on the wavelength, exposure to UV radiation results in the 
formation of oxidative damage and two major classes of photoproducts, i.e., 
cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidone 
photoproducts (6-4 PPs) (Pfeifer 1997; Meador et al. 2000; Mouret et al. 2006). By 
direct excitation, UV-C and UV-B induce the same pattern of DNA damages, namely 
CPDs and 6-4PPs, but the generation of CPDs occurs at ~4 fold higher frequency 
compared to 6-4PPs (Meador et al. 2000). UVA has been shown to induce oxidative 
damage and CPDs by an indirect mechanism involving the excitation of endogenous 
photo-sensitizers (Kielbassa et al. 1997; Perdiz et al. 2000). In human cells, 
photoproducts are solely removed via the NER pathway. UV light-induced CPDs, in 
comparison to 6-4PPs, cause only small distortions of the helical conformation (Kim 
et al. 1995; McAteer et al. 1998). As a consequence CPDs are only poorly 
recognized by XPC protein, the key initiator complex of the GGR pathway (Sugasawa 
et al. 2001; Kusumoto et al. 2001). Hence, in mammals, an accessory protein is 
needed for the efficient recognition and removal of CPDs from the genome (Hwang et 
al. 1999; Tang et al. 2000). This accessory factor specialized on the recognition of UV 
lesions has been discovered by virtue of its pronounced affinity for UV-irradiated DNA 
(Hirschfeld et al. 1990; Keeney et al. 1994) and is usually referred to as DDB (for 
damaged DNA-binding). It has been suggested that DDB acts by accelerating the 
recruitment of XPC protein to UV lesions (Fujiwara et al. 1999; Fitch et al. 2003; 
Moser et al. 2005). DDB is a heterodimer that consists of DDB1 (127 kDa) and DDB2 
(48 kDa), with the smaller subunit being encoded by the XPE gene (Rapić-Otrin et al. 
2003). DDB1 forms a molecular adapter for the Cul4A-Roc1 ubiquitin ligase complex 
(Shiyanov et al. 1999) and mediates the ubiquitylation of target proteins comprising 
DDB2 itself (Nag et al. 2001) and XPC protein (Sugasawa et al. 2005). 
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 2.3.2  Cisplatin 
 
Cisplatin has been used in the context of this thesis as a well characterized alkylating 
agent that induces DNA lesions recognized by the human NER system. It is a 
chemotherapeutic drug widely used for the treatment of many malignant tumors in 
both human and veterinary medicine (Cohen & Lippard 2001). Cisplatin generates a 
variety of structural modifications in DNA, the most abundant being intrastrand 
crosslinks formed between adjacent purine bases. A minor fraction of cisplatin-DNA 
lesions consists of interstrand crosslinks, i.e., covalent bonds between the two 
complementary strands (Sanderson et al. 1996; Moggs et al. 1997; Siddik 2003; 
Rabik & Dolan 2006). Intrastrand cisplatin crosslinks are removed slowly by the NER 
pathway (Moggs et al. 1996; Furuta et al. 2002; Chen et al. 2003). The process of 
homologous recombination is thought to participate in the removal of the interstrand 
crosslinks (Bergstralh & Sekelsky 2008; Mladenova & Russev 2008). 
 
 
 2.3.3  Formaldehyde 
 
Formaldehyde (FA; chemical structure: HCHO) is a physiologic metabolite that is 
formed as a by-product of methionine and choline degradation and as an 
intermediate of synthesis of amino acids, purines and pyrimidines. The normal FA 
concentration in human blood plasma has been reported in the range of 13-97 µmol/l 
(Szarvas et al. 1986; Heck et al. 1985). There are also many exogenous FA sources. 
For example, this strong smelling flammable and colorless gas, which is soluble in 
water, is utilized for disinfection and tissue conservation. It is also employed as a 
preservative in many cosmetics. FA is widely used by industry to fabricate numerous 
household products and various building materials that include insulation and 
pressed wood products containing urea-formaldehyde resins. FA can also be found 
as a component in natural products like wood, apples and pears. Combustion of 
wood, kerosene and natural gas as well as tobacco releases FA into the environment 
(Emri et al. 2004; Heck & Casanova 2004; IARC 2004; Naya & Nakanishifehlen 
2005). To estimate the extent of FA air pollution, indoor and outdoor air 
concentrations have been measured in an Italian city. The indoor value (0.016 ppm) 
was clearly higher than the concentration (0.006 ppm) measured in the outdoor air 
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(Fuselli et al. 2006). Air levels higher than 0.1 ppm cause irritation of eyes, nose and 
throat and provoke allergic reactions mainly of the skin (CPSC 1997). Previous 
studies have shown that FA displays genotoxic and mutagenic properties in 
mammalian cells (Ma & Harris 1988; Conaway et al. 1996; IARC 2004). In 2004, FA 
was classified by the International Agency for Research on Cancer (IARC) as 
carcinogen to humans (group 1) based on the significantly increased risk for 
nasopharyngeal cancer found in several cohort and case-control studies with 
industrial workers (Vaughan et al. 2000; Hauptmann et al. 2004). There is also a 
correlation between leukemia and occupational FA exposure (IARC 2004; 
Hauptmann et al. 2003). In rodent studies, exposure to FA by inhalation induced 
squamous cell carcinomas in the nasal cavities of the animals (Casteel et al. 1987). 
FA is taken up by food, absorbed through the skin or inhaled. In rats, it has been 
shown that 90% of FA is deposited in the upper respiratory tract after long-term 
inhalation (Dallas et al. 1985; Heck et al. 1985). However, blood FA levels did not 
change after inhalation exposure in rats, monkeys or humans (Casanova et al. 1988; 
Heck et al. 1983, 1985), most probably due to a rapid metabolism in the respiratory 
tract (CIIT 1999). At low concentrations, inhaled FA is detoxified in the epithelial 
layers of nasal cavity. Free FA is conjugated to glutathione by glutathione S-
transferase, thus forming the conjugate S-hydroxymethylglutathione (Figure 3). 
Subsequently, FA dehydrogenase oxidizes S-hydroxymethylglutathione to S-
formylglutathione, which is further hydrolyzed to formate and glutathione (Heck et al. 
1988). Formate is either excreted with the urine or dehydrogenated to carbon dioxide 
being exhaled (Oro et al. 1959). 
Cells treated with low FA doses (100 nM) respond with enhanced cell proliferation 
and decreased apoptosis (Marcsek et al. 2007) whereas, at higher concentrations 
(>10 µM), FA inhibits cell proliferation and promotes apoptosis (Tyihak et al. 2001). 
These apparently contradicting effects suggest that FA becomes cytotoxic upon 
saturation of the glutathione system. 
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Figure 3: Metabolism of FA. (A) Conjugation with glutathione (G-SH), leading to the 
formation of S-formylglutathione. (B) S-formylglutathione is then hydrolyzed to 
glutathione and formate. (C) Formate is either excreted in the urine (D) or is further 
metabolized to water and carbon dioxide, which is exhaled. 
 
Free reactive FA is genotoxic as it generates DNA-protein crosslinks (DPXs), induces 
sister chromatid exchanges and micronuclei (Heck & Keller 1988; Hubal et al. 1997; 
Merk & Speit 1998). The primary mutagenic effect of FA is attributed to the formation 
of DPXs (Casanova et al. 1991; Conaway et al. 1996), whereby a DNA-binding 
protein is covalently linked to the amino group of a DNA base (Figure 4). Studies 
performed in rats and monkeys indicate that DPX formation is proportional to the 
tissue FA concentration (Casanova et al. 1991, 1994). A fraction of these DPXs are 
reverted by hydrolysis combined with proteolytic degradation (Quievryn & Zhitkovich 
2000). However, there is very limited information of the repair of DPXs besides their 
spontaneous removal. Some biochemical studies suggest that the NER system is 
involved in the elimination of DPXs (Minko et al. 2002; Reardon et al. 2006). 
(D) 
G-SH 
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Figure 4: Basic structure of a DNA-protein crosslink induced by FA exposure. 
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 3  AIMS OF THE THESIS 
 
The primary aim of this work was to establish a live-cell imaging system based on 
differentially fluorescent protein tags to study the dynamic trafficking of DNA damage 
recognition factors (primarily XPC and DDB) involved in the human NER pathway. 
The second aim was to validate this live-cell imaging system by monitoring the 
response of DNA damage recognition factors to standard genotoxic stress induced by 
exposure to UV radiation or treatment with the alkylating agent cisplatin. The third 
goal was to apply the live-cell imaging system to test how XPC and DDB respond to 
FA-induced DPXs. 
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 4  MATERIALS AND METHODS  
 
 4.1  Cell culture 
 
Simian virus 40-transformed human XP-C fibroblasts (GM16093) and wild-type 
fibroblasts (GM00637) were purchased from Coriell Cell Repository (Camden, New 
Jersey, USA). These fibroblasts were cultured in Dulbecco's Modified Eagle Medium 
(DMEM; Gibco) containing 10% fetal bovine serum (FBS; Gibco), 0.1 U/ml penicillin 
and 0.1 µg/ml streptomycin (Gibco). All cells were incubated at 37°C in a humidified 
atmosphere containing 5% CO2. 
 
 
 4.2  Mammalian expression vector and cloning 
 
The complementary DNA coding for human DDB2, XPC, XPA and XPD were fused to 
the sequence of various fluorescence proteins using the restriction enzymes (New 
England BioLabs) listed in Table 1. Vectors containing the sequence of fluorescent 
proteins (pEGFP, pECFP, pEYFP) were ordered from Clontech. The pmRFP1 - C3 
was kindly provided by Dr. Elisa May (University of Konstanz, Germany); pEGFP–
DDB2-C1 was a gift from Dr. Stuart Linn (University of California, Berkeley, USA) and 
XPD-pEGFP-N1 from Jean-Marc Egly (University Louis Pasteur, Strasbourg, 
France). The plasmid pEGFP-Ub-C1 was purchased from the non-profit organization 
Addgene (www.addgene.org). 
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Table 1: Plasmids and restriction enzymes used in the course of this thesis 
Protein Original plasmid Target vector 
Restriction 
enzymes 
DDB2 pEGFP-DDB2-C1 pmRFP1- C3 BamH1 
DDB2 pEGFP-DDB2-C1 pECFP-C1 BamH1 
DDB2 pEGFP-DDB2-C1 pEYFP-C1 BamH1 
XPC XPC-pcDNA pEGFP-N3 Kpn1, Xma1 
XPC XPC-pEGFP-N3 pmRFP1-C3 Kpn1, Sma1 
XPC XPC-pEGFP-N3 pECFP-C1 Kpn1, Sma1 
XPC XPC-pEGFP-N3 pEYFP-C1 Kpn1, Sma1 
XPD XPD-pEGFP-N1 pmRFP1-C3 Kpn1, EcoR1 
 
 
The expression vectors were constructed basically following the methods described 
by Sambrook et al. (1989). Each plasmid was digested for 2 h using the appropriate 
restriction buffers (New England BioLabs) and enzymes as indicated in Table 1. To 
avoid self-ligation, vectors treated with enzymes generating blunt ends were 
dephosphorylated using calf intestine alkaline phosphatase (CIP; New England 
BioLabs) for 1 h at 37°C. Digestion mixtures were loaded on a 1% agarose gel for 
purification. The fragment coding for the proteins of interest (insert) and the linearized 
acceptor vector were extracted using QIAquick Gel Extraction Kit (QIAGEN) or 
Geneclean Turbo Kit (Q-BIOgene). Subsequently, 90 fmol of the insert and 30 fmol of 
the linearized vector were ligated by T4 DNA ligase (Promega) in overnight 
incubations at 16°C or for 4-h incubations at 25°C. If necessary, site-directed 
mutagenesis (QuickChange II Site-Directed Mutagenesis Kit; Stratagene) was used 
to correct the frame or to insert a STOP codon. The respective oligonucleotide 
primers are listed in Table 2. All final clones were sequenced (Microsynth) to exclude 
accidental mutations introduced elsewhere in the complementary DNA. 
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Table 2: PCR primers used for site-directed mutagenesis 
Plasmid Oligonucleotide sequences 
pmRFP1-DDB2 
Insertion primers 
5’-CTCCACCGGCGCCACTGTACAAGTACTC-3’ 
5’-GAGTACTTGTACAGTGGCGCCGGTGGAG-3’ 
pmRFP1-XPC 
Stop primers 
5’-CATTTGAGAAGCTGTGACCCGGGATCCACC-3’ 
5’-GGTGGATCCCGGGTCACAGCTTCTCAAATG-3’ 
pmRFP1-XPD 
Insertion primers 
5’-CTCCACCGGCGCCACTGTACAAGTACTC-3’ 
5’-GAGTACTTGTACAGTGGCGCCGGTGGAG-3’ 
 
 
 4.3  Induction of local DNA damage and immunochemistry 
 
One day before transfection, 400’000 cells were seeded into 6-well plates containing 
glass cover slips. At a confluence of 90%, the cells were transfected with 1 µg DNA 
using 4 µl FuGENE HD transfection reagent (Roche). For co-transfections, 0.75 µg of 
each plasmid and 6 µl transfection reagent were used. After 4-h incubations, the 
transfection mixture was replaced by complete medium and the cells were grown for 
another 18 h at 37°C. 
Following removal of the cell culture medium and rinsing with phosphate-buffered 
saline (PBS), the cells were irradiated through 5-µm diameter pores of a 
polycarbonate filter (Millipore) using a UV source (254 nm, 150 J/m2) at a dose rate 
of 3 W/m2. Thereafter, cells were incubated in complete DMEM for 10 min at 37°C. 
Subsequently, the cells were washed with PBS and fixed with 4% paraformaldehyde 
in PBS for 15 min at room temperature. After washing in PBS, the cells were 
permeabilized five times with 0.1% TWEEN 20 in PBS and the DNA was denatured 
with 0.07 M NaOH in PBS for 8 min. The cells were washed five times with 0.1% 
TWEEN 20 in PBS and treated with 20% FCS in PBS for 30 min at 37°C to inhibit 
unspecific binding. Subsequently, the cells were incubated (1 h, 37°C) with the 
primary antibody directed against CPDs (TDM-2, MBL International Corporation), 
diluted 1:3000 with 5% FCS in PBS. After incubation with the primary antibody, cells 
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were washed five times with 0.1% TWEEN 20 in PBS and blocked twice with 20% 
FCS in PBS for 10 min. Samples were treated with the appropriate Alexa Fluor dye-
conjugated secondary antibody (Invitrogen; dilution 1:400) and incubated for 30 min 
at 37° C. Finally, the cells were washed five times with 0.1% TWEEN 20 in PBS and 
the nuclei were stained with HOECHST 33342 (Invitrogen; 200 ng/ml) for 10 min. The 
samples were finally washed three times with PBS and fixed on an objective slide 
using Fluoromount G (Interchim). These samples were analyzed through a 60x oil 
immersion objective using a Leica TCS SP5 confocal microscope to quantify both the 
green fluorescence of the transfected fusion protein and the red fluorescence 
representing UV lesions detected by monoclonal antibodies. 
 
 
 4.4  Host cell reactivation assay  
 
This DNA repair assay is based on the in vivo removal of DNA lesions from an 
irradiated expression vector coding for the Photinus (firefly) luciferase enzyme. The 
results are normalized for transfection efficiency by concomitant co-expression of the 
Renilla luciferase from an undamaged vector. For that purpose, 400’000 human 
fibroblasts were seeded in 6-well plates. The next day, at a confluence of 90%, 
samples were transfected in triplicates with 0.5 µg plasmid DNA and 0.5 µg luciferase 
mixture containing UV irradiated (1000 J/m2) pGL3 (coding for Photinus luciferase) 
and phRL-TK (unirradiated, coding for Renilla luciferase) in a ratio of 10:1. The 
FuGENE HD reagent (Roche) was used for transfection, which was carried out in 
complete medium supplemented with FA (Fluka) as indicated. After 4 h at 37°C, the 
transfection mixture was replaced by complete cell culture medium and the 
fibroblasts were incubated for another 18 h. Subsequently, the cells were lysed in 500 
µl 5x Passive Lysis Buffer (Promega) following the manufacturer’s instructions. The 
lysates were cleared by centrifugation and, subsequently, the expression of Photinus 
and Renilla luciferase activity was determined using the Dual-Luciferase reporter 
assay system (Promega). The luminescent signal from the luciferase reaction was 
monitored in a MLX microplate luminometer (Dynex). All results were normalized by 
calculating the ratios between Photinus luciferase activity and the internal Renilla 
standard. 
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 4.5  Fluorescence recovery after photo bleaching 
 
Cells were grown for 24 h on cover slips and transfected with vectors coding for 
fluorescence-tagged repair factors using the FuGENE HD reagent. After 4 h at 37°C, 
the transfection mixture was replaced with complete medium and incubated for 
another 18 h. To measure the influence of UV light, formaldehyde or cisplatin on 
protein mobility, fluorescence recovery after photobleaching (FRAP) experiments 
were performed with a 63x oil immersion objective using a Leica TCS SP5 confocal 
microscope. During the FRAP experiment, cells were kept at 37°C and 5% CO2 in a 
climate chamber. The nuclear fluorescence within the region of interest (ROI) was 
photobleached for 2.2 sec at 100% intensity with a 488 nm Argon ion laser. To 
increase the bleaching efficiency, a 405 nm UV laser in addition to the argon ion 
laser was used for GFP-DDB2, GFP-OGG1 and their mutants. Before and after 
bleaching, confocal image series were recorded at 120-ms time intervals (typically 
75 prebleach and 200 postbleach frames) at low laser intensity. Simultaneously, a 
reference ROI of the same size was measured for each time point. Confocal image 
series were recorded with a frame size of 128 × 128 pixels and a scanner frequency 
of 1400 Hz. Mean fluorescence intensities of the bleached region were corrected 
with the reference ROI and normalized to the mean of the last 30 prebleach values. 
 
 
 4.6  Treatments with DNA damaging agents 
 
To study the response of the DNA damage recognition factors to genotoxic stress, 
cells were exposed either to FA (Fluka), cisplatin (Sigma-Aldrich) or UV irradiation. 
Four h after transfection, the transfection mixture was replaced by complete medium 
supplemented with formaldehyde (0 µM – 100 µM) or cisplatin (5 µM) and cells were 
incubated for another 16 hours. For FRAP experiments in cells exposed to UV-
irradation, the tranfection mixture was replaced by complete medium and incubated 
for another 16-20 h, followed by irradiation with a dose of 10 J/m2 using a UV-C 
source (254 nm wavelength). 
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 5  RESULTS 
 
 5.1  Production of fluorescent fusion proteins  
 
To analyze the DNA repair processes of living cells in real-time, several subunits of 
the nucleotide excision repair (NER) pathway were tagged with enhanced cyan, 
enhanced green, monomeric red or enhanced yellow fluorescent proteins (ECFP, 
EGFP, mRFP, EYFP) as summarized in Table 3. For that purpose, appropriate 
molecular cloning was performed to introduce the complementary DNA of interest 
into a final vector carrying the sequence for one of the fluorescent tags (see Material 
& Methods). One of these vectors also codes for a GFP-tagged ubiquitin moiety 
(pEGFP-Ub-C1) that has been purchased from a commercial source to monitor DNA 
damage-induced ubiquitylation reactions. 
 
Table 3: Overview of fluorescent constructs. The letters N and C describe the 
position of the gene of interest relative to the fluorescent protein (N, amino-terminal; 
C, carboxy-terminal). 
Color XPC DDB2 XPD Ubiquitin 
green XPC-pEGFP-N3 pEGFP-DDB2-C1 XPD-pEGFP-N1 pEGFP-Ub-C1 
red pmRFP1-XPC-C3 pmRFP1-DDB2-C3 pmRFP1-XPD-C3  
cyan pECFP-XPC-C1 pECFP-DDB2-C1   
yellow pEYFP-XPC-C1 pEYFP-DDB2-C1   
 
 
All constructs were sequenced to exclude accidental mutations in the complementary 
DNA and, subsequently, transfected into mammalian cells to monitor overall 
expression levels and sub-cellular distributions. As expected, the DNA damage 
recognition subunits XPC (Figure 5) and DDB2 (data not shown) display a clear 
nuclear localization regardless of the color of the fluorescent tag. 
A different distribution was observed for XPD protein, which appears mainly localized 
to the cytoplasm (Figure 6). This finding suggests that the fluorescently tagged XPD 
fusions were not correctly incorporated into the 10-subunit transcription factor TFIIH 
 28 
complex (Santagati et al. 2001) or, alternatively, that the tagged XPD was produced 
in vast excess in comparison to the other TFIIH subunits. As a consequence, no 
further studies have been conducted with the XPD fusion products. 
 
 
 
 
 
 
    green        red      yellow   cyan 
 
Figure 5: Nuclear localization of XPC tagged with the different fluorescent proteins 
encoded by XPC-pEGFP (green), pmRFP1-XPC (red), pEYFP-XPC (yellow) and 
pECFP-XPC (cyan). 
 
 
    pmRFP1-XPD  Hoechst      merge  
 
Figure 6: pmRFP1-XPD is mainly localized to the cytoplasm. Hoechst, DNA staining 
to visualize the nucleus. 
 
Finally, the N-terminal GFP-tagged ubiquitin, which remains active as shown 
elsewhere (Dantuma et al. 2006), is mainly detected in the nucleus although it is 
found to a lower extent in the cytoplasm as well. 
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 5.2  Functionality of the fusion proteins 
 
The fusion proteins were examined in terms of their functionality by two different 
methods. An overall repair activity was determined by monitoring excision activity in a 
host-cell reactivation assay. Second, the damaged DNA-binding activity was 
measured by monitoring the capacity of each fusion product to accumulate at foci of 
DNA damage induced by UV irradiation through the pores of polycarbonate filters. 
 
 
 5.2.1  Repair proficiency in the host-cell reactivation assay 
 
To test whether any of the introduced fluorescent tags affect the repair activity, the 
constructs were compared in a host-cell reactivation assay that has been developed 
to measure NER activity in living cells (Carreau et al. 1995). NER-deficient XP-C 
fibroblasts were transfected with a dual luciferase reporter system accompanied by 
an expression vector coding for the XPC protein to restore the repair activity of the 
cell line. One of the reporter plasmids (pGL3) contains the UV-irradiated 
complementary DNA coding for firefly luciferase. The second plasmid (phRL-TK), 
carrying the non-irradiated Renilla luciferase gene, is needed to normalize the values 
for transfection efficiency. After 18-h incubations, the firefly luciferase activity in cell 
lysates was measured in a luminometer, followed by normalization against the 
Renilla luciferase control. We found that all XPC fusion proteins corrected the repair 
defect of XP-C cells. In fact, the human fibroblasts expressing pECFP-XPC, pEYFP-
XPC or pXPC-EGFP (thereafter referred as XPC-GFP) display essentially the same 
repair activity as those containing the non-tagged version of XPC protein (expressed 
from pcDNA-XPC), indicating that the fusion of this particular NER factor to a 
fluorescent partner does not interfere with its physiological function in DNA repair. As 
a control, we demonstrated that the excision repair activity was not rescued when the 
cells were transfected with the empty pcDNA vector (Figure 7). 
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Figure 7: Host-cell reactivation assay measuring the repair activity in living cells. 
DNA repair is indicated as the percentage of luciferase gene reactivation after 
transfection of XP-C fibroblasts with vectors coding for full-length XPC protein alone 
or in conjugation with a fluorescent partner. The luciferase activity observed with full-
length XPC was taken as the reference value and set to 100%; pcDNA, empty 
expression vector resulting in background host-cell reactivation levels. Error bars 
represent standard deviations (n = 3). 
 
 
 5.2.2  DNA damage recognition proficiency 
 
The fluorescently tagged repair proteins were also analyzed for their relocalization to 
repair foci induced by irradiation with UV-C light (254 nm wavelength). Human NER-
proficient fibroblasts were grown on cover slips and transfected with plasmids coding 
for the different fluorescent fusion products. Subsequently, the cells were UV-
irradiated through the pores of polycarbonate filters, thereby generating foci of DNA 
damage. This exposure to UV light results in the formation of two major classes of 
photoproducts, i.e., cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) 
pyrimidone photoproducts (Pfeifer 1997). Both type of damages are efficiently 
recognized and repaired by the NER pathway, thus leading to a local accumulation of 
the repair proteins at lesion sites. The detection of CPDs with specific antibodies, 
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following fixation of the cells, was used to confirm that the assembly of NER 
complexes took place at sites of DNA damage. We found that all fusion proteins with 
XPC and DDB2, listed in Table 3, efficiently accumulate at these repair foci. Figure 8 
illustrates the co-localization of pEGFP tagged DDB2 (thereafter referred as GFP-
DDB2) with foci of UV lesions in the nuclei of human fibroblasts. 
 
(A)        (B) 
GFP-DDB2    CPDs  Hoechst  YFP-DDB2     CPDs  Hoechst 
 
Figure 8: Expression of GFP-DDB2 (A) and YFP-DDB2 (B) in repair-proficient human 
fibroblasts. The cells were irradiated with UV-C light (150 J/m2) through the 5-µm 
pores of polycarbonate filters and subjected to fixation 15 min after this treatment. 
The formation of CPDs was demonstrated by immunochemical staining with the red 
dye Alexa 546. Nuclei were stained using Hoechst dye, which visualizes the cellular 
DNA (blue). 
 
 
 5.3  Live cell imaging 
 
Live cell imaging using fluorescently labeled proteins provides several innovative 
opportunities to monitor the dynamics of individual repair factors as well as the 
assembly and disassembly of multi-subunit repair complexes within the physiologic 
microenvironment of living cells. Fluorescence recovery after photobleaching (FRAP), 
for instance, is already widely applied in many fields to determine the dynamics of 
GFP-tagged proteins in living cells. In this study, FRAP was employed to study the 
changes in the mobility of repair proteins when cells are exposed to genotoxic stress. 
For that purpose, the fluorescent tag of the fusion protein is bleached across a 
defined area of the nucleus. Thereafter, the recovery of the fluorescence signal within 
the bleached area is monitored over time to assess DNA damage-induced 
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differences in protein mobility, which are indicative of the engagement of a particular 
factor with DNA damage responses. 
 
 
 5.3.1  Processing of FRAP data 
 
The fluorescence signal of GFP-tagged proteins was detected through a confocal 
laser scanning microscope by measuring average pixel values in defined regions of 
interest (ROI 1) within the nuclear compartment. An image of each cell comprising 
the ROI 1 was collected before bleaching and at several time points during the 
subsequence fluorescence recovery. Simultaneously, a reference ROI (ROI 2) of the 
same size was taken for each time point in a neighboring area of the same nucleus. 
Representative data sets obtained from three human fibroblasts are displayed in 
Table 4. 
 
Table 4: Example of raw data generated during the first three seconds of typical 
FRAP experiments with GFP-tagged NER factors. 
Fibroblast 1 Fibroblast 2 Fibroblast 3 
Time ROI 1 ROI 2 Time ROI 1 ROI 2 Time ROI 1 ROI 2 
0 
0,11 
0,23 
0,35 
0,46 
0,57 
0,69 
0,8 
0,91 
1,03 
1,15 
1,26 
1,38 
1,49 
57365,73 
57406,01 
57819,33 
56798,87 
57339,97 
56965,47 
56591,24 
56921,09 
56829,88 
56564,04 
56570,92 
57145,74 
56656 
56881,53 
56169,96 
55031,26 
55542,75 
55685,71 
54942,32 
54247 
54491,97 
55217,46 
55187,1 
55382,44 
55112,12 
55679,75 
55256,41 
54685,27 
0 
0,12 
0,24 
0,36 
0,47 
0,58 
0,7 
0,81 
0,93 
1,04 
1,16 
1,27 
1,39 
1,5 
35969,83 
36150,12 
35538,16 
35211,04 
36221,41 
35319,37 
35436,32 
35077,65 
35868,76 
34662,02 
34876,13 
35376,61 
35459,93 
35250,07 
37139,01 
37234,79 
37442,36 
36342,04 
36259,82 
36156,63 
36672,25 
36242,09 
35690,51 
35895,57 
36253,6 
35648,91 
36232,5 
36177,65 
0 
0,11 
0,23 
0,35 
0,46 
0,57 
0,69 
0,8 
0,91 
1,03 
1,15 
1,26 
1,38 
1,49 
44765,48 
44375,8 
44322,45 
43864,89 
44089,14 
43848,82 
43780,25 
44186,07 
44418,51 
44111,12 
44132,02 
43704,47 
43920,58 
44335,96 
42778,68 
42433,66 
42583,57 
42230,04 
43154,39 
42757,1 
42620,19 
42464,79 
42258,67 
42250,83 
41346,89 
42647,46 
42500,04 
42240,63 
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1,61 
1,72 
1,84 
1,95 
2,07 
2,18 
2,3 
2,41 
2,52 
2,64 
2,75 
2,88 
56161,18 
56494,39 
56412 
56591,28 
56544,07 
56320,06 
56214,55 
56097,07 
56238,58 
56352,47 
56840,8 
56992,53 
54432,07 
54089,83 
54870,54 
54700,04 
54745,68 
54388,54 
54606,97 
54653,34 
54123,91 
54591,12 
54720,38 
54523,96 
1,62 
1,74 
1,85 
1,97 
2,08 
2,19 
2,31 
2,42 
2,54 
2,65 
2,77 
2,89 
34962,57 
35649,76 
35293,3 
34827,99 
35867,58 
34674,13 
35635,93 
34580,13 
36142,89 
34574,8 
35721,89 
35822,27 
36538,75 
36144,2 
35949,66 
36360,46 
36462,53 
36216,3 
36421,61 
35721,57 
36037,02 
36378,13 
36667,23 
36880,4 
1,61 
1,72 
1,84 
1,95 
2,07 
2,18 
2,3 
2,41 
2,52 
2,64 
2,75 
2,88 
43887,62 
43927,28 
44051,95 
42459,67 
43795,64 
44363,96 
43262,43 
43190,21 
43658,67 
43349,82 
43913,07 
43123,86 
42377,35 
42372,5 
41753,98 
41609,39 
42383,81 
42011,45 
42577,6 
41548,96 
42064,88 
42036,88 
41425,04 
42125,76 
 
 
 In each single experiment, fluorescence recovery was monitored about 280 times 
translating to a total observation period of 30 seconds. Average values from at least 
10 independent cells were used to determine the final fluorescence recovery plot. 
During the data analysis, the fluorescence signals were corrected for laser-induced 
fluctuations by dividing the intensities of ROI 1 by those in ROI 2 at each time point. 
Subsequently, all data were normalized to the pre-bleach intensities (Figure 9). 
 
Figure 9: Equation used for normalization and correction of laser intensity and 
photobleaching signals in FRAP experiments. 
 
 
 
 
 
Fluorescence signal = ROI 1(t) 
ROI 2 (t) 
ROI 2 (t5,4sec-8,5sec) 
ROI 1(t5,4sec-8,5sec) 
x 
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 5.3.2  Comparison of EGFP mobility by FRAP analysis 
 
In a first series of experiments, FRAP was applied to cells expressing GFP without 
any fusion partner. As shown in Figure 10, the GFP moiety exhibits a very fast and 
complete recovery after photobleaching, indicating that GFP itself diffuses freely in 
the cell and does not bind to DNA or any other macromolecular structure. From these 
findings it can be concluded that the GFP tag does not disturb the mobility of repair 
proteins through unspecific interactions with nuclear constituents (Houtsmuller et al. 
1999; Rademakers et al. 2003; Luijsterburg et al. 2007). 
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Figure 10: Mobility of pEGFP moieties within the physiologic nuclear environment of 
living human fibroblasts. A defined nuclear area was bleached with a 488-nm laser 
and monitored at regular intervals of 120 milliseconds. The upper (bold) line shows 
the fluorescence recovery with the GFP polypeptide alone. The lower (grey) line 
reflects the mobility of the XPC-GFP fusion product in undamaged cells (n = 10; error 
bars represent standard errors of the mean). 
 
The overall fluorescence recovery was clearly retarded when the small GFP moiety 
was linked to the DNA damage recognition factor XPC (Figure 10). This substantial 
change in the diffusion rate cannot be explained solely by the increased size of the 
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fusion product (Hoogstraten et al. 2008) but rather indicates that the majority of XPC 
molecules bind constitutively to nuclear macromolecules such as DNA, thereby 
reducing its mobility. A similar effect can be observed when GFP is linked to the DNA 
damage recognition factor DDB2 (Figure 11). 
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Figure 11: Mobility of GFP moieties within the physiologic nuclear environment of 
living human fibroblasts. A defined nuclear area was bleached with a 488-nm argon 
ion laser and monitored at regular intervals of 120 milliseconds. The upper (bold) line 
shows the recovery of GFP alone. The lower (grey) line reflects the mobility of the 
GFP-DDB2 fusion product in undamaged cells (n = 10; error bars represent standard 
errors of the mean). 
 
 
 5.4  Application of FRAP – Live cell imaging upon genotoxic stress 
 
Next, the FRAP analysis was used to investigate the effect of distinctly different 
genotoxic insults on the dynamics of the two DNA damage recognition factors XPC 
and DDB2 tested as GFP fusion proteins. For that purpose, human fibroblasts were 
transfected with XPC-GFP or GFP-DDB2 and exposed either to UV light, cisplatin or 
formaldehyde. 
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 5.4.1  Response to DNA lesions induced by UV light 
 
The initial recognition step of UV radiation-induced DNA lesions is carried out by 
DDB2 and XPC (Venema et al. 1991; Hwang et al. 1999). When the protein 
movement was monitored before and after UV irradiation, both XPC and DDB2 
displayed the expected retardation in nuclear mobility (Figure 12). In the case of XPC 
protein, the baseline recovery of fluorescence reached a plateau at about 90% of the 
pre-bleach value, indicating that a fraction of this repair subunit is continuously bound 
to chromatin even in the absence of exogenously induced DNA damage 
(Hoogstraten et al. 2008; Camenisch & Naegeli 2009). In any case, the increased 
proportion of DNA-bound DDB2 and XPC proteins when the cells are exposed to UV 
light (Figure 12) is consistent with their function in the recognition and repair of DNA 
photoproducts. 
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Figure 12: Changes of FRAP kinetics of XPC-GFP and GFP-DDB2 following UV 
irradiation. Human XP-C fibroblasts were transfected with vectors XPC-pEGFP (A) or 
pEGFP-DDB2 (B). Cells were irradiated with a UV-C dose of 10 J/m2. The upper bold 
line represents the recovery of proteins in untreated cells. The lower grey curve 
shows the decreased mobility of the damage recognition factors in the presence of 
UV lesions (n = 10; error bars represent standard errors of the mean). 
 
 
 5.4.2  Response to DNA lesions induced by cisplatin 
 
It has been shown that cisplatin-induced DNA intrastrand crosslinks are removed by 
the NER pathway (Moggs et al. 1996; Furuta et al. 2002; Chen et al. 2003). 
Therefore, we tested the effect of a cisplatin treatment on the mobility of the initial 
recognition factors DDB2 and XPC in human fibroblasts. In both series of 
experiments, the exposure to cisplatin induced a moderate but significant reduction of 
the freely diffusing protein fraction, confirming the involvement of these NER subunits 
in the recognition of cisplatin-induced DNA lesions (Figure 13). In the case of DDB2, 
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we observed only a transient immobilization, suggesting that this particular subunit 
does not form stable interactions with cisplatin-damaged DNA. 
 
Figure 13: Changes of FRAP kinetics of XPC-pEGFP and pEGFP-DDB2 following a 
cisplatin treatment. Human fibroblasts were transfected with XPC-pEGFP (A) or 
pEGFP-DDB2 (B) and, for 16 h, exposed to cisplatin at a dose of 5 µM. The upper 
bold line represents the recovery of fluorescence in untreated cells. The lower grey 
curve reflects the decreased mobility of the damage recognition factors in the 
presence of cisplatin-DNA lesions (n = 10; error bars represent standard errors of the 
mean). 
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 5.4.3  Response to DNA lesions induced by formaldehyde 
 
Formaldehyde (FA) is another cross-linking agent that is able to damage the DNA 
double helix. In contrast to cisplatin, FA mainly induces the covalent binding of 
proteins to DNA, i.e. it forms DNA-protein crosslinks (DPXs) (Grafstrom et al. 1983; 
Merk & Speit 1998; Ridpath et al. 2007). Although it is unclear which DNA repair 
pathway is directly responsible for the removal of DPXs, recent reports suggest that 
the NER pathway may be involved in a final step during the processing of DPXs in 
mammalian cells (Minko et al. 2002; Reardon & Sancar, 2006). To test whether DPXs 
are recognized by the NER subunits DDB2 or XPC, human cells exposed to a non-
cytotoxic FA concentration (75 µM) were subjected to FRAP analysis. Surprisingly, 
we found that the nuclear dynamics of GFP-DDB2 is significantly diminished by the 
low-dose FA treatment (Figure 14). In contrast, the mobility of XPC-GFP is not 
affected by this low-dose FA exposure (Figure 15). In co-transfection experiments, 
we further found that XPC protein is not significantly immobilized by FA-induced 
crosslinks even when its interaction partner DDB2 is simultaneously overexpressed 
(Figure 16). 
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Figure 14: FRAP analysis of pEGFP-DDB2-transfected fibroblasts subsequently 
exposed for 16 h to a FA concentration of 75 µM. The upper bold line represents the 
fluorescence recovery of pEGFP-DDB2 in untreated cells whereas the lower gray 
curve shows the decreased DDB2 dynamics in FA-treated cells (n = 10; error bars 
represent standard errors of the mean). 
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Figure 15: FRAP analysis of XPC-pEGFP-transfected fibroblasts subsequently 
exposed for 16 h to a FA concentration of 75 µM. The bold line represents the 
fluorescence recovery of XPC-pEGFP in untreated cells whereas the lighter gray 
curve shows that the XPC dynamics is not affected by the FA treatment (n = 10; error 
bars represent standard errors of the mean). 
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Figure 16: Mobility of XPC-pEGFP, detected by FRAP, in human XP-C fibroblasts 
co-transfected with pmRFP1-DDB2 and XPC-pEGFP and subsequently exposed for 
16 h to a FA concentration of 75 µM. The bold line represents the fluorescence 
recovery of XPC-pEGFP in untreated mRFP-DDB2-expressing cells, whereas the 
gray curve shows the fluorescence recovery of XPC-GFP in the presence of mRFP-
DDB2 upon exposure to 75 µM FA (n = 10; error bars represent standard errors of 
the mean). See the following section for further details on the dual transfection with 
differentially fluorescent fusions. 
 
An important control experiment is to exclude that the GFP tag itself may be 
responsible in part for the changes of GFP-DDB2 dynamics observed in Figure 14 
following FA treatments. For that purpose, FRAP analyses were performed in cells 
transfected with the empty vector pEGFP, by which the GFP moiety is expressed 
without any fusion partner. Figure 17 demonstrates that FA does not interfere with the 
very fast and complete recovery of fluorescence in these cells containing the free 
GFP moiety. 
Taken together, our protein dynamics experiments indicate that the nuclear mobility 
of DDB2 but not XPC is retarded by exposure to a non-cytotoxic FA concentration. As 
DDB2 is generally thought to be specialized on the recognition of UV lesions, these 
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results suggest an unexpected involvement of this factor in processing or at least in 
the detection of FA-induced DPXs. 
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Figure 17: FRAP analysis plots demonstrating the rapid diffusion of GFP in both 
untreated (bold line) and FA-treated fibroblasts (gray line). The cells were transfected 
with pEGFP and exposed to 75 µM FA for 16 hours (n = 10; error bars represent 
standard errors of the mean). This control experiment shows that the rapid movement 
of GFP is not retarded by the FA treatment. 
 
 
 5.5  Simultaneous expression of two tagged proteins 
 
A principal goal of this thesis was to set up appropriate experimental conditions to 
monitor the cellular co-localization of different protein partners participating in the 
NER pathway. The wide repertoire of fluorescent tags (Table 3) allows for the 
simultaneous visualization of multiple proteins in living cells. Therefore, separate 
NER subunits were expressed in the same target cells as fusion proteins in 
association with differentially fluorescent partners.  
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 5.5.1  Co-expression of fluorescent DDB2 and XPC proteins  
 
The transfection procedure was adapted to express simultaneously two proteins in 
mammalian cells (for details see the Materials & Methods section). To exclude that 
co-transfections may interfere with the damage recognition function of XPC and 
DDB2 proteins, UV radiation foci were generated by irradiating the cells with UV-C 
light (150 J/m2) through the pores of a Millipore filter. Subsequently, the localization of 
XPC-GFP and mRFP-DDB2 (co-expressed in the same cells) was monitored 
separately using the respective emission spectrum. Figure 18 demonstrates that 
XPC-GFP and mRFP-DDB2 accumulate simultaneously in the same DNA repair foci, 
implying that both proteins are functional and do not impede the accumulation of 
each other. The presence of UV lesions in these DNA repair foci was confirmed by 
immunochemical staining for CPDs with the blue dye Alexa 405. 
 
    mRFP-DDB2 (red)    XPC-GFP (green)  CPDs (blue)  
 
 
Figure 18: Co-localization of mRFP-DDB2 and XPC-GFP in repair foci generated by 
UV-C irradiation (150 J/m²). Blue, CPDs stained with the dye Alexa fluor 405. Upper 
panels, original color display of the images; lower panels, black-and-white pictures. 
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 5.5.2  Co-expression of fluorescent DDB2 and the ubiquitin polypeptide 
 
DDB2 forms a heterodimer with DDB1, which in turn represents a molecular adaptor 
of the Cul4A-Roc1 ubiquitin ligase complex (Shiyanov et al. 1999; Groisman et al. 
2003; Angers et al. 2006; Sugasawa 2009). This DDB-Cul4A-Roc1 ligase promotes 
the ubiquitylation of protein substrates, i.e., it mediates a post-translational 
modification reaction whereby ubiquitin is covalently linked to proteins (Wilkinson 
2000). It is conceivable that, by this ubiquitylation pathway, the DDB1-DDB2 
heterodimer may stimulate the proteolytic degradation of proteins cross-linked to 
DNA (Reardon & Sancar 2006). Thus, to address the possible function of DDB1-
DDB2 in the processing of DPXs, we monitored the nuclear ubiquitin turnover in 
living cells by FRAP analyses. For that purpose, human fibroblasts were co-
transfected with mRFP-DDB2 and ubiquitin-GFP (Ubi-GFP). 
First, we observed in these nuclear dynamics experiments that the over-expression 
of DDB2 leads to a slightly decreased mobility of ubiquitin (Figure 19A), consistent 
with a function of the DDB2 subunit in mediating the covalent ubiquitylation of nuclear 
proteins. Upon exposure of human fibroblasts to 75 µM FA, the degree of ubiquitin 
immobilization was enhanced (Figure 19B), lending further support to the conclusion 
that DDB2 stimulates protein ubiquitylation reactions in response to DPX formation. 
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Figure 19: Nuclear dynamics of ubiquitin in human fibroblasts expressing the 
ubiquitin-GFP (Ubi-GFP) fusion alone (upper bold line) or in the presence of 
mRFP1-DDB2 (lower gray line). (A) Untreated cells. (B) Cells exposed to 75 µM FA 
(n = 10; error bars represent standard errors of the mean). 
 
 
 5.6  Impairment of NER through DPXs 
 
DDB2 has an exquisite affinity for UV-irradiated DNA and is well known to stimulate 
the excision of bulky UV-lesions, i.e., CPDs and (6-4) photoproducts, by mediating 
the recruitment of downstream NER factors (Fitch et al. 2003; Moser et al. 2005). 
However, the observed reduced mobility of DDB2 in FA-treated cells (Figure 14) 
suggests that non-toxic concentrations of FA interfere with the nuclear trafficking of 
DDB2, such that the repair of UV-induced photoproducts may be indirectly inhibited. 
Three different experimental methods were employed to test this hypothesis. 
 
 
 5.6.1  Determination of overall UV repair activity in formaldehyde-exposed 
cells 
 
The possible effect of FA exposure on the removal of UV lesions was first tested 
using the host-cell reactivation assay. For that purpose, NER-proficient human 
fibroblasts were transfected with the dual luciferase reporter system, including the 
UV-damaged reporter vector, as described before (section 4.4). After an 18-h 
incubation time, the effect of FA treatment was assessed by monitoring the ratio of 
luciferase activities in cell lysates (Figure 20). No significant inhibition of firefly 
luciferase expression was observed at a FA concentration of 10 µM. However, the 
firefly luciferase activity was progressively reduced at FA concentrations of 25–125 
µM, thus reflecting an inhibitory effect of this compound on the repair of UV lesions. 
An approximately 50% inhibition of repair activity was detected at a FA level of 100 
µM (Figure 20). Higher concentrations were not tested because, in combination with 
the transfection procedure, FA levels of 200 µM or above exerted cytotoxic effects 
(data not shown). 
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Figure 20: UV repair activity in fibroblasts determined by host-cell reactivation assay. 
After transfection in FA-containing medium, cells were treated with different 
concentrations (0–125 µM) of FA for another 18 hours (n = 12; error bars represent 
standard deviations). 
 
 
 5.6.2  Analysis of protein dynamics in UV-irradiated cells 
 
In a next step, we employed FRAP analyses to test how FA affects the nuclear 
trafficking of DDB2 and XPC in UV-irradiated cells. As already shown in Figure 12, 
the dynamics of both NER subunits is significantly retarded in UV-irradiated cells, 
consistent with their role in the detection and repair of UV lesions. Additional 
exposure to FA did not change the dynamics of the GFP-DDB2 polypeptide (Figure 
21A), suggesting that the DDB2 subunit does not discriminate between UV- and FA-
induced lesions. In UV-irradiated cells, however, the dynamics of XPC-GFP was 
changed by the FA treatment, in a way that XPC displays slightly increased protein 
mobility (Figure 21B). This result obtained in FRAP experiments suggested that the 
detection of UV lesions by XPC protein may be impeded by FA exposures. 
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Figure 21:  Effect of a combined UV irradiation and FA treatment on the nuclear 
dynamics of DDB2 (A) and XPC protein (B) in human fibroblasts. The UV-C dose 
was 10 J/m2 and the FA concentration 75 µM. The dark grey curve represents the 
protein mobility in the nuclei of untreated cells. The decreased mobility upon UV 
irradiation is displayed in light grey. The black curve shows the mobility in cells 
subjected to the combined treatment of UV light and FA. 
 
 
 5.6.3  Accumulation at local UV-light induced repair foci 
 
To confirm the FA effects observed in FRAP analyses (Figures 14 and Figure 21B), 
the UV-induced accumulation of DDB2 and XPC was monitored directly in cells 
locally exposed to UV light (section 4.3). Fibroblasts where transfected with either 
GFP-DDB2 or XPC-GFP, treated with 100 µM FA for 18 h, and irradiated with UV-C 
(150 J/m2) through polycarbonates filters. Subsequently, the cells were fixed and 
CPDs were stained by cytochemistry. In each case, the accumulation of GFP-tagged 
proteins in repair foci was determined relative to the fluorescence signal obtained 
from the immunochemical staining of UV lesions (Figure 22). These quantifications of 
protein fluorescence relative to the local level of photoproducts showed that FA 
reduces the ability of DDB2 to accumulate at sites of UV lesions (Figure 22A). 
Similarly, we found that the FA pretreatment also reduced the efficiency by which 
XPC protein accumulates in UV-induced repair foci.  
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Figure 22: Diminished damage-specific accumulation of GFP-DDB2 (A) or XPC-GFP 
(B) in FA-treated fibroblasts. Human fibroblasts were UV-irradiated through micropore 
filters and, after an incubation time of 15 min, subjected to immunochemical staining 
for the visualization of UV lesions (n = 50; error bars represent standard deviations). 
The GFP signal at the sites of lesions was normalized to the amount of DNA damage. 
These quantifications showed that FA significantly (p < 0.005) decreases the ability of 
both DDB2 and XPC to relocate to nuclear areas containing UV photoproducts. 
 
From these results, we conclude that FA impedes NER activity by interfering with the 
dynamic trafficking of the recognition factors DDB2 and XPC in the chromatin of living 
cells. This interference with the normal protein movement leads to the reduced 
accumulation of the DDB2 and XPC subunits to NER substrates. 
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 6  DISCUSSION 
 
The purpose of the present thesis was to apply different cell biology methods, i.e., 
host-cell reactivation assay, fluorescence recovery after photobleaching (FRAP) and 
the induction of fluorescence-based repair foci, to examine the effect of low FA 
concentrations on DNA repair activity in living human skin fibroblasts. FA is an 
important industrial raw substance used for the synthesis of chemicals, building 
materials, home insulation and many consumer goods. Common sources of 
exposure to this highly reactive compound are, in addition to tobacco smoke, wood 
products, paints and varnishes, resins used as adhesives and binders, textiles, 
carpets, leather and disinfectants. As a preservative against bacterial contamination 
and chemical degradation, cosmetics often contain FA itself or FA-releasing 
compounds like diazolidinyl urea (Rastogi 2000). The maximal allowed concentration 
of FA in skin creams regulated by the EU Cosmetic Directive is 0.2% (2 mg/g). Thus, 
large numbers of people are exposed to FA through the skin, where it easily diffuses 
into deeper layers (Robbins et al. 1984) and often causes contact dermatitis and 
photosensitivity (Agner et al. 1999; Vilaplana & Romaguera 2000). There is no known 
epidemiological evidence for an increased skin tumor risk due to dermal FA 
exposure, but an elevated mortality resulting from skin cancers has been reported 
among embalmers (Walrath & Fraumeni 1983). Another environmental challenge to 
the human skin is the nearly permanent formation of UV lesions in the DNA resulting 
from natural sunlight or artificial light sources. Both the UV-B (280 – 315 nm 
wavelength) and UV-A spectrum (315 – 400 nm wavelength) reach the proliferating 
cell layer in the skin (Mouret et al. 2006) and generate two major classes of 
mutagenic and carcinogenic DNA photoproducts, i.e., CPDs and 6-4 PPs (described 
in the Introduction). In human cells, these UV lesions are solely removed via NER 
system, of which the “global genome repair” (GGR) sub-pathway provides the major 
protective action against UV-B and UV-A radiation-induced skin cancer (Satoh et al. 
1993; Reardon et al. 1997; Reardon & Sancar 2006; Kuraoka et al. 2000). Although 
many mechanistic details are still highly debated, it is generally thought that the 
different factors of the GGR machinery are assembled on damaged DNA sites in a 
sequential and coordinated manner (Volker et al. 2001; Politi et al. 2005). In 
particular, the GGR sub-pathway is initiated by the binding of the dimeric DDB protein 
(consisting of DDB1 and DDB2), followed by the trimeric XPC-RAD23B-CNT2 
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complex, transcription factor TFIIH (consisting of 10 subunits), XPA, RPA (consisting 
of 3 subunits) and the two DNA endonucleases XPF-ERCC1 and XPG (Drapkin & 
Reinberg 1994; O´Donovan et al. 1994; Matsunga et al. 1995; Bessho et al. 1997; 
Mu et al. 1997; de Laat et al. 1998; Tang et al. 2000; You et al. 2003; Camenisch et 
al. 2006). Subsequently, the single-stranded gap resulting from dual DNA incision at 
lesion sites is processed by further recruitment of a DNA polymerase (δ, ε or κ) 
together with its accessory factors and a DNA ligase (Shivji et al. 1995; Araújo et al. 
2000). In view of the ability of FA to generate bulky DPXs (Casanova et al. 1994; 
Conaway et al. 1996), which may impede macromolecular movements within the 
nuclear compartment, the present thesis addresses the question of whether exposure 
to FA interferes with the dynamic trafficking of GGR factors searching for DNA lesions 
and, hence, retard their coordinated assembly at damaged sites to be repaired. 
Previous publications reported the inhibitory effect of FA on different DNA repair 
pathways. For example, DNA damage (O6-methylguanine) caused by N-methyl-N-
nitrosourea is removed less efficiently from human bronchial cells concomitantly 
exposed to 100-300 µM FA (Grafstrom 1990). Also, the rejoining of single-stranded 
DNA breaks after X-ray irradiation was inhibited in the same cells exposed to FA at a 
concentration level of 100 µM (Grafstrom et al. 1983). Exposure of human fibroblasts 
to 300 µM FA has been estimated by the same authors to generate 2-3 lesions/109 
daltons, translating to about 1 lesion per 600’000 base pairs (Grafstrom et al. 1984). 
Interestingly, in the study of Grafstrom et al. (1983) DNA repair patch synthesis by the 
NER machinery was also inhibited in the presence of FA. However, substantially 
higher FA concentrations (600 µM-1 mM) were required to inhibit DNA repair 
synthesis following the induction of UV lesions or the formation of DNA adducts 
elicited by the ubiquitous chemical carcinogen benzo[a]pyrene diol-epoxide. Thus, 
these earlier findings indicated that the DNA ligation step (responsible for the direct 
rejoining of X-ray-induced single-stranded DNA breaks) is more sensitive than the 
DNA repair synthesis machinery to inhibition upon FA exposure. In a more recent 
study, Emri et al. (2004) used comet (single-cell gel electrophoresis) assays to 
monitor the transient appearance of single-stranded DNA breaks that were taken as a 
surrogate indicator of cellular NER activity, which generates DNA incision 
intermediates, after UV irradiation. They found that human keratinocytes and 
fibroblasts exposed to low FA concentrations (10-100 µM) prior to UV irradiation 
showed a delayed kinetics of single-strand break formation after UV-C or UV-B 
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irradiation. Thus, Emri et al. (2004) came to the conclusion that even low FA levels 
are able to interfere with the assembly of NER complexes at UV lesion sites. In the 
present thesis, we used a highly specific host-cell reactivation assay to confirm the 
inhibitory action of FA on the repair of UV lesions. This assay determines the 
proficiency of human cells in recruiting the NER system to remove UV lesions from a 
luciferase reporter gene sequence, thus reactivating expression of an easily 
detectable luciferase enzyme. This approach demonstrated that the overall NER 
activity is significantly reduced in the presence of 25 µM FA, whereas an 
approximately 50% inhibition of repair activity was detected at a FA concentration of 
75 µM (Fig. 20). This host-cell reactivation assay yielded a no-effect-level of 10 µM. 
Two different lines of evidence support the conclusion that this low-dose FA effect on 
the excision of UV lesions arises from an impaired nuclear trafficking of GGR factors 
in UV-irradiated cells. Using the FRAP technique, we observed that the mobility of 
DDB2 protein (tested as a green-fluorescent fusion construct) is significantly reduced 
in cells exposed to 75 µM FA compared to the untreated controls (Fig. 14). This 
difference in fluorescence recovery indicates that the overall diffusion rate of DDB2 
protein is diminished upon FA treatment, implying that in response to the FA-induced 
formation of DPXs this initial recognition factor may be retarded in its molecular 
movements necessary to reach UV-damaged DNA sites within the nuclear 
compartment. This view is consistent with the finding that the accumulation of DDB2 
protein (tested again as a green-fluorescent fusion construct) in foci of local UV 
damage was significantly reduced upon FA treatment (Fig. 22). A lower accumulation 
in locally UV-irradiated nuclear areas was also observed for XPC protein (Fig. 22), 
which is an interaction partner of DDB2 and another key sensor of DNA damage in 
the NER pathway (see “Introduction”). Taken together, these results suggest that FA-
induced DPXs interfere with the normal dynamic trafficking of two different guardians 
of DNA integrity (DDB and XPC proteins) that act as the initial damage detectors in 
the GGR process. In the cellular context, DDB2 is always present in association with 
DDB1, which is a molecular adapter for the Cul4A-Roc1 ubiquitin ligase complex 
(Shiyanov et al. 1999) and, hence, mediates the ubiquitylation of target proteins (Nag 
et al. 2001; Sugasawa et al. 2005). Therefore, we tested whether the DDB1-DDB2 
dimer may stimulate the ubiquitylation of proteins following FA treatments. 
Ubiquitylation is a post-translational protein modification that may serve to initiate the 
degradation of cross-linked proteins by the proteasomal complex (Hochstrasser 
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1996). To address the possible function of DDB1-DDB2 in the ubiquitylation process 
following the formation of DPXs, we used the FRAP analysis to monitor the nuclear 
ubiquitin turnover in living cells. These experiments were made possible by a genetic 
construct, in which the ubiquitin moiety is fused to green fluorescent protein. First, we 
observed that the over-expression of DDB2 leads to a reduced nuclear mobility of 
ubiquitin (Figure 19A), consistent with a function of the DDB2 subunit in mediating 
the ubiquitylation of proteins, thus decreasing the pool of free nuclear ubiquitin. Upon 
exposure of human fibroblasts to 75 µM FA, the immobilization of ubiquitin by 
expression of DDB2 was further enhanced (Figure 19B), indicating that DDB2 
stimulates protein ubiquitylation reactions in response to DPX formation. 
The results of the present thesis provide an alternative mechanism that may explain 
how low-dose FA treatments delay the GGR response following UV irradiation. 
According to our findings, the observed inhibitory effect of FA on the repair of UV 
lesions is caused at least in part by the impaired trafficking of GGR factors, leading to 
their delayed recruitment to lesion sites, rather than by a catalytic slow-down of 
enzymes involved in the synthesis of repair patches or the final DNA ligation step. In 
a wider perspective, such an impairment of DNA repair, affecting the removal of 
mutagenic lesions arising from both endogenous and exogenous agents, may help to 
explain the wide spectrum of genotoxic effects exerted by FA. In fact, this compound 
has been shown to induce DNA strand breaks, sister-chromatid exchanges, 
chromosomal aberrations leading to micronuclei formation, as well as point mutations 
(Natarajan et al. 1983; Craft et al. 1987; Crosby et al. 1988; Recio et al. 1992; Merk & 
Speit 1998). DNA strand breaks, sister-chromatid exchanges and micronuclei are 
generated in the same concentration range that also causes a reduction in cloning 
efficiency, indicating that these clastogenic effects of FA are inherently related to the 
ability of DPXs to disrupt the DNA replication machinery or subsequent mitotic 
processes (Merk & Speit 1998; Heck & Casanova 1999). On the other hand, it is 
uncertain how FA induces point mutations (mainly base transversions) as they have 
been found in the p53 tumor suppressor gene of FA-induced nasal tumors in rats 
(Recio et al. 1992). The observed inhibition of DNA repair following FA exposure may 
result in the replication of incompletely repaired DNA templates that, in turn, may give 
rise to such tumorigenic base transversions or other point mutations. In any case, a 
synergistic effect may be expected when the skin is concomitantly exposed to FA and 
UV light from natural or artificial sources. A reduced DNA repair activity due to the 
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interference of FA-induced DPXs with the nuclear dynamics of individual GGR factors 
is likely to enhance the photo-carcinogenic risk to humans. 
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 8  ZUSAMMENFASSUNG 
 
Die genetische Information wird ständig verschiedenen physikalischen und 
chemischen Einflüssen ausgesetzt, die zur Schädigung der DNA führen. Um das 
Genom zu schützen, prozessiert die Nukleotid-Exzisionsreparatur (NER) eine große 
Vielfalt von nicht verwandten DNA-Addukten, einschließlich solche die zum Beispiel 
durch UV-Licht oder Cisplatin hervorgerufen werden. Das Ziel dieser Arbeit war, die 
entsprechenden Reparaturproteine mittels Fluoreszenz so zu markieren, dass deren 
Aktivität in lebenden Fibroblasten untersucht werden kann. Mit dieser Methode soll 
die Wirkung von Formaldehyd, ein weit verbreitetes genotoxisches Agens, auf die 
NER-Reaktion geprüft werden. Für die Bestimmung der intrazellulären Aktivität der 
Reparaturproteine wurden die Kinetik ihrer Ansammlung an Schadstellen und ihre 
Dynamik in „fluorescence recovery“ Experimenten ermittelt. Diese Echtzeit-
Untersuchungen ergaben, dass Formaldehyd schon in niedrigen, nicht-zytotoxischen 
Konzentrationen die nukleäre Beweglichkeit der XPC- und DDB2-
Erkennungsproteine einschränkt, womit ihre Rekrutierung an Schadstellen 
verlangsamt wird. Weitere Echtzeit-Versuche mit fluoreszenzmarkiertem Ubiquitin 
weisen darauf hin, dass DDB2 die Protein-Ubiquitylierung in Folge der Einwirkung 
von Formaldehyd stimuliert. Somit zeigen unsere Untersuchungen, dass 
formaldehydinduzierte Vernetzungen die Aktivität der NER-Faktoren behindern und 
auf dieser Weise die Exzisionsreparatur von mutagenen DNA-Schäden 
beinträchtigen. 
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